2018 (v1)
Publication
Objectives: The aim of this study was to assess the current evidence for long-acting Β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations (FDCs) in the treatment of COPD. Materials and methods: A systematic literature search of randomized controlled trials published in English up to September 2017 of LABA/LAMA FDCs...
Uploaded on: April 14, 2023